The FDA revoked the emergency use authorization for hydroxychloroquine, claiming it is unlikely to be effective against COVID-19. However, frontline doctors like Joseph Varon in Houston continue to report high survival rates when the drug is used early and in combination with other treatments. Critics argue the medical establishment is suppressing cheap, off-patent drugs in favor of expensive alternatives like remdesivir and future vaccines.
